Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1459-1466

  Wald, Anna ^b   Leisenring, Wendy ^c   Van Burik, Jo Anne ^c   Bowden, Raleigh A ^a  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CORTICOSTEROID; PREDNISONE; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0031010201     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516480     Document Type: Article

References (15)

1. Pannuti C, Gingrich R, Pfaller MA, Kao C, Wenzel RP. Nosocomial pneumonia in patients having bone marrow transplant. Cancer 1992; 69:2653-4.
2. Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant 1993;12:121-4.
3. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990;17(suppl 6):10-3.
4. Iwen PC, Reed EC, Armitage JO, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 1993;14:131-9.
5. Morrison VA, Haake RJ, Weisdorf DJ. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 1994;96:497-503.
6. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987;2:175-81.
7. Aisner J, Schimpff SC, Bennett JE, Young VM, Wiernik PH. Aspergillus infections in cancer patients; association with fireproofing materials in a new hospital. JAMA 1976;235:411-2.
8. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978;118:49-53.
9. Lentino JR, Rosenkranz MA, Michaels JA, Kurup VP, Rose HD, Rytel MW. Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 1982;116:430-7.
10. Sarubbi FA Jr, Kopf HB, Wilson MB, McGinnis MR, Rutala WA. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982;125:33-8.
11. Walsh TJ, Dixon DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis, and treatment. Eur J Epidemiol 1989;5:131-42.
12. Buckner CD, Clift RA, Appelbaum FR, et al. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone Marrow Transplant 1991;7(suppl 2):6-8.
13. Storb R, Leisenring W, Deeg HJ, et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]. Blood 1994;83: 2749-56.
14. Petersen FB, Buckner CD, Clift RA, et al. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand J Infect Dis 1987;19:559-67.
15. Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik J. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 1996;173: 1208-15.